author-photo

Sabine Leiblein

Leipzig University

62

Papers

794

Citations

Citation Trend

Filter By

Papers (43) Sort By

Journal Conference Others

Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible

2020 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
UNSUPERVISED HIERARCHICAL CLUSTERING OF PRE-TREATMENT IMMUNOPHENOTYPIC FEATURES IDENTIFIES MDS PATIENTS AT HIGH RISK OF DISEASE PROGRESSION AFTER ALLOGENEIC TRANSPLANTATION: PS1339

2019
Show All
- Source
- Cite
- Save
Citations (0)
Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV)

2017 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Successful Treatment of Patients With Newly Diagnosed/Untreated Light Chain Multiple Myeloma With a Combination of Bendamustine; Prednisone and Bortezomib (BPV)

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with newly diagnosed/untreated Multiple Myeloma

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma

2015 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia

2014 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (3)